Unicycive
UNCY
Unicycive (UNCY) news
Recent news
Unicycive Therapeutics announces second quarter 2026 financial results and provides business update
AInvest Wire · Aug 12, 2026ImportantUnicycive Therapeutics shares down 45.8% after US FDA declines to approve co's kidney disease drug
AInvest Wire · Jun 30, 2026ImportantUnicycive Therapeutics shares down 36.9% premarket after US FDA declines to approve co's kidney disease drug
AInvest Wire · Jun 30, 2026Unicycive Therapeutics - FDA CRL based on third-party manufacturing deficiencies identified in June 2025
AInvest Wire · Jun 30, 2026Unicycive Therapeutics - FDA has not conducted inspection of third-party manufacturing vendor for resubmitted NDA
AInvest Wire · Jun 30, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.